Skip to main content
. 2020 Jun 4;13(2):195–202. doi: 10.3892/mco.2020.2063

Figure 2.

Figure 2

Outcomes of endocrine therapy for stage IV breast cancer. Kaplan-Meier curves of the indicated clinical effects of endocrine therapy are shown. (A) The median PFS was 85 weeks, (B) the median TTF was 68 weeks, and (C) the median OS was 379 weeks. PFS, progression-free survival; TTF, time to treatment failure; OS, overall survival.